Showing results (201-210 of 2,909) with videos related to
Sort By:
Pageof 291
Arthritis & Rheumatology (Hoboken, N.J.)|September 7, 2016
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled TrialsMegan E B Clowse, Daniel J Wallace, Richard A Furie, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2017
Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's SyndromeRohan Sharma, Valerie M Harris, Joshua Cavett, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 26, 2017
Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus NephritisRong Fu, Chaohuan Guo, Shuang Wang, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 26, 2017
Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled TrialD H Solomon, J Kay, J Duryea, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2017
Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled TrialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2017
Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of ThrombosisElizabeth Papalardo, Zurina Romay-Penabad, Rohan Willis, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 7, 2018
The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health: A Systematic Review and Network Meta-AnalysisFaith Matcham, James Galloway, Matthew Hotopf, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 16, 2018
Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1Michihiro Kono, Takashi Kurita, Shinsuke Yasuda, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 2, 2018
ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: A Randomized, Double-Blind StudyMark C Genovese, Michael E Weinblatt, Jacob A Aelion, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 12, 2020
Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki DiseaseIsabelle Koné-Paut, Stéphanie Tellier, Alexandre Belot, et al.Pageof 291